Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice

Gene Therapy

Volumn 6, Issue 7, 1999, Pages 1331-1335

  Tsukamoto, H ^a,b   Wells, D J ^c   Brown, S C ^a   Serpente, P ^a   Strong, P N ^d   Drew, J ^a   Inui, K ^b   Okada, S ^b   Dickson, J G ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Duchenne muscular dystrophy; dystrophin; EBNA 1; Epstein Barr virus vector; Gene therapy; Muscle

Indexed keywords

DYSTROPHIN; PLASMID DNA; RECOMBINANT PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; DNA REPLICATION ORIGIN; DUCHENNE MUSCULAR DYSTROPHY; EPSTEIN BARR VIRUS; EXPRESSION VECTOR; GENE TARGETING; GENE TRANSFER; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIRUS GENE;

ANIMALS; CHROMOSOMES; DYSTROPHIN; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; PLASMIDS; TIME FACTORS;

ANIMALIA; EUKARYOTA; HUMAN HERPESVIRUS 4;

EID: 0032794069     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300944     Document Type: Article

References (38)

1. Emery AEH. Duchenne Muscular Dystrophy, 2nd edn. Oxford Medical Publications: Oxford, 1993.
2. Brown SC, Dickson G. Duchenne Muscular Dystrophy. In: Dickson G (ed). Molecular and Cell Biology of Human Gene Therapeutics. Chapman & Hall: London, 1995, pp 261-280.
3. Acsadi G et al. Human dystrophin expression in mdx mice after intra-muscular injection of DNA constructs. Nature 1991; 352: 815-818.
4. Acsadi G et al. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 1995; 1: 129-140.
5. Dickson G. Gene therapy for Duchenne muscular dystrophy. Chem Indust 1997; 8: 294-297.
6. Dickson G et al. Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene. Hum Genet 1991; 88: 53-58.
7. CV diaphragm muscle fibers increases sarcolemmal stability. Gene Therapy 1997; 4: 401-408.
8. CV skeletal muscle fibers. Gene Therapy 1998; 5: 59-64.
9. Phelps SF et al. Prevention of muscular dystrophy by full-length and internally truncated dystrophins. Hum Mol Genet 1995; 4: 1251-1258.
10. Wells DJ et al. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Hum Mol Genet 1995; 4: 1245-1250.
11. Dunckley MG, Wells DJ, Walsh FS, Dickson G. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum Mol Genet 1993; 2: 717-723.
12. Fassati A et al. Genetic correction of dystrophin deficiency and skeletal muscle remodelling in adult mdx mouse via transplantation of retroviral producer cells. J Clin Invest 1997; 100: 620-628.
13. Vincent N et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 1993; 5: 130-134.
14. Dodds E et al. Lipofection of cultured mouse muscle cells: a direct comparison of Lipofectamine and DOSPER. Gene Therapy 1998; 5: 542-551.
15. Trivedi R, Dickson G. Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. J Neurochem 1995; 64: 2230-2238.
16. Yanagihara I, Inui K, Dickson G, Okada S. Expression of full-length human dystrophin cDNA in MDX mouse by HVJ-liposome injection. Gene Therapy 1996; 3: 549-553.
17. Dickson G. Gene transfer to muscle. Biochem Soc Trans 1996; 24: 514-519.
18. Wells KE et al. Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle. FEBS Lett 1997; 407: 164-168.
19. Wells DJ et al. Evaluation of plasmid DNA for in vivo gene therapy: factors affecting the number of transfected fibers. J Pharm Sci 1998; 87: 763-768.
20. Margolskee RF. Epstein-Barr virus expression vectors. Curr Topics Microbiol Immunol 1992; 158: 67-95.
21. Yates JL, Guan N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 1991; 65: 483-488.
22. Krysan PJ, Haase SB, Calos MP. Isolation of human sequences that replicate autonomously in human cells. Mol Cell Biol 1989; 9: 1026-1033.
23. Jankelevich S, Kolman JL, Bodnar JW, Miller G. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J 1992; 11: 1165-1176.
24. Mellon P, Parker R, Gluzman Y, Maniatis T. Identification of DNA sequences required for transcription of the human α-1-globin gene in a new SV40 host-vector system. Cell 1981; 27: 279-288.
25. Queen C, Baltimore D. Immunogloblin gene-transcription is activated by downstream sequence elements. Cell 1983; 33: 341-348.
26. Mecsas J, Sugden B. Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Ann Rev Cell Biol 1987; 3: 87-108.
27. Dyrks T et al. Generation of bA4 from the amyloid protein precursor and fragments thereof. FEBS Lett 1993; 335: 89-93.
28. Whitesell L, Rosolen A, Neckers LM. Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines. Mol Cell Biol 1991; 11: 1360-1371.
29. Pan LC, Margolskee RF, Blau HM. Cloning muscle isoforms of neural cell adhesion molecule using an episomal shuttle vector. Somat Cell Mol Genet 1992; 18: 163-177.
30. Deiss LP, Kimchi A. A genetic tool used to identify thioredoxin as a mediator of growth inhibitory signal. Science 1991; 252: 117-120.
31. Trojan J et al. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor 1. Proc Natl Acad Sci USA 1992; 89: 4874-4878.
32. Lindenboim L, Anderson D, Stein R. The use of Epstein-Barr virus-based shuttle vectors in rat PC12 cells. Cell Mol Neurobiol 1997; 17: 119-127.
33. Krysan PJ, Calos MP. Epstein-Barr virus-based vectors that replicate in rodent cells. Gene 1993; 136: 137-143.
34. Wohlgemuth JG et al. Long-term expression from autonomously replicating vectors in mammalian cells. Gene Therapy 1996; 3: 503-512.
35. Belharz MW et al. Quantitation of muscle precurser cell activity in skeletal muscle by northern blot analysis of MyoD and myogenin expression: application to dystrophic (mdx) mouse muscle. Mol Cell Neurosci 1992; 3: 326-331.
36. DiMario JX, Uzman A, Strohman RC. Fiber regeneration is not persistent in dystrophic (mdx) mouse skeletal muscle. Dev Biol 1991; 48: 314-321.
37. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1997; 270: 725-727.
38. Sherratt TG, Vulliamy T, Strong PN. Evolutionary conservation of the dystrophin central rod domain. Biochem J 1992; 287: 755-759.